Chairman -
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
(405) 271-2730(W)
Upcoming Events
| Date
| Topic
| Presenter
| Location
| Time
|
|
|
|
|
| 6:30pm
|
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
.--->
| NOTICE: Due to recent changes in federal tax laws, corporate sponsors of our dinners and continuing education programs have asked that only ACTIVE MEMBERS, ASSOCIATE MEMBERS or STUDENT MEMBERS of OSHP attend the dinner and program. Pre-meeting REGISTRATION is required. Please contact your District Chair. Licensed pharmacists who may be Prospective Members may attend as a guest of an Active Member. |
Continuing Education - 2010
| Date
| Topic
| Presenter
| Sponsor
| CE Credit
|
| 1/25
| The Management of Acute Hypertension: A Critical Care Focus
| Denise H. Rhoney, Pharm.D., FCCP, FCCM
| EKR Therapeutics (Courney Chastain)
| 1 hr.
|
| 3/25
| LUSEDRA (fospropofol disodium)
| Alex Bekker, M.D., Ph.D.
| Eisai (John Wally)
| 1 hr.
|
| 5/6
| Overview, Outcomes & Management for Complicated Intra-abdominal Infections
| Ronald Greenfield, M.D.
| Pfizer (Alan Imhoff)
| 1 hr.
|
| 7/29
| APEX: The Need to Develop & Implement an Effective Antibiotic Optimization Program
| Robert P. Rapp, Pharm.D., FCCP
| Pfizer (Alan Imhoff)
| 1 hr.
|
| 8/17
| Expanded Role of Parenteral Nutrition in Critically-Ill Patients
| Jeffrey Binkley, Pharm.D.
|
| 1 hr.
|
Continuing Education - 2009
| Date
| Topic
| Presenter
| Sponsor
| CE Credit
|
| 1-22
| Chemotherapy Extravasation
| David Frames, Pharm.D.
| Topo Target
| 1 hr.
|
| 2-25
| Insomnia Update
| Shelley Seilers, Pharm.D., BCPP
| Sanofi-Aventis
| 1 hr.
|
| 3-18
| DVT Prophylaxis in Acutely Ill Medical Patients and in Patients Undergoing Abdominal Surgery
| Paul Dobesh, Pharm.D., FCCP, BCPS
| Sanofi-Aventis
| 1 hr.
|
| 5-18
| Atrial Fibrilation: An Escalating Cardiovascular Disease with Significant & Economic Consequences
| Mark H. Durso, Pharm.D.
| Sanofi-Aventis
| 1 hr.
|
| 7-23
| Update on Pertussis Outbreaks in the US
| Kelly Straka-Showalter, Pharm.D.
| GlaxoSmithKline
| 1 hr.
|
| 9-10
| Update on Fungal Infections
| Clifford Vlodaver, M.D.
| Pfizer
| 1 hr.
|
| 11-11
| Short talk about Synagis® and FluMist®.
| Rob Baxter, Clinical Marketing Manager
| Medimmune
|
|
Continuing Education - 2008
| Date
| Topic
| Presenter
| Sponsor
| CE Credit
|
| 1-31
| Schizophrenia-Seroquel XL
| Chris Thomas, Pharm.D.
| AstraZeneca
| 1 hr.
|
| 2-21
| New Options for Treatment & Prophylaxis of DVT/PE
| Jean Keddissi, M.D.
| GlaxoSmithKline
| 1 hr.
|
| 3-13
| Slowing the Progression of Atherosclerosis with Crestor
| Richard Mullvain, Pharm.D.
| Astra-Zeneca
| 1 hr.
|
| 5-22
| Appropriate DVT/PE Prophylaxis in Hospitalized Medical Patients: Review of Pharmacologic Options
| Thomas Campbell, Pharm.D., BCPS.
| Sanofi-aventis
| 1 hr.
|
| 7-29
| An Update in Clinical Toxicology Including Pediatric Poisonings & Envenomations
| William Banner, M.D., Ph.D.
| Fougera
| 1 hr.
|
| 10-9
| Stroke Awareness: An update on the secondary prevention of stroke
| Jennifer Whaley, Pharm.D., BCPS
| Sanofi-Aventis
| 1 hr.
|
| 11-6
| Update on MRSA
| Ronald Greenfield, M.D.
| Pfizer
| 1 hr.
|
| 11-20
| Therapeutic Pillars of Cancer Supportive Care
| David Beribeault, R.Ph., BCOP
| Amgen
| 1 hr.(ACPE Approved credit)
|
|
|
Last Updated on Wednesday, 08 September 2010 08:48 |
